Radcliffe Capital Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Radcliffe Capital Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-310,350	Closed	-$3.14M	–	974
2022 Q3	$3.14M	Buy	310,350 +9,900	+3%	+$100K	0.08%	440
2022 Q2	$3.02M	Hold	300,450	–	–	0.07%	474
2022 Q1	$3.01M	Buy	300,450 +450	+0.2%	+$4.5K	0.07%	451
2021 Q4	$2.98M	Buy	+300,000	New	+$2.97M	0.08%	382

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Radcliffe Capital Management's ARCK Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 310,350 shares — an estimated $3.14M sold.

Radcliffe Capital Management first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $3.14M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Radcliffe Capital Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 310,350 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $3.14M.
Radcliffe Capital Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Radcliffe Capital Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $3.14M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.